NanoTemper was awarded a prize for being Germany’s most innovative Start-Up company. The prize was awarded for the MST technology that NanoTemper introduced in 2010. NanoTemper’s Monolith instruments rapidly convinced users around the world in basic research as well as pharma and biotech companies. To date, hundreds of scientists use the technology which allows them to carry out experiments that have not been possible before. “We are very happy that NanoTemper’s new approaches to bio-analytics have been recognized by the jury and we will further extend our range of innovative instruments in the future,” says Dr. Stefan Duhr, CEO of NanoTemper.
Most recent content
Guide: Prometheus Panta Parameters Explained
This guide provides an overview of the key analytical parameters obtained with Prometheus Panta, their definitions and practical relevance for protein characterization and drug development.
Practical Guide: Quality Control Strategies for Membrane Proteins
When working with membrane proteins, whether you’re troubleshooting aggregation, testing new solubilization strategies, or deciding when to switch detergents read this guide for practical solutions.
Powering Precision: How Automated Analytical Devices are Driving Smarter Biomanufacturing
Learn about Prometheus Panta C: A next-generation stability characterization platform that's helping biomanufacturers bring automation into the analytical core of their development and process control
Unfolding insights: How nanoDSF is reshaping biotherapeutics development at Johnson & Johnson Innovative Medicine
Dr. Marius Müller of Johnson & Johnson Innovative Medicine shares insights from questions about the use of nanoDSF™ technology for ID-testing and at several late stages of biotherapeutics development.
NanoTemper Announces Prometheus Panta C: Powering Biopharma Breakthroughs from Preclinical to Commercial Manufacturing
NanoTemper Technologies announces the launch of Prometheus Panta C, a solution designed to meet the evolving needs of biopharmaceutical development—from preclinical phase to commercial manufacturing.
3 trends shaping the future of Biomanufacturing
Expert Marius Müller, PhD, Team Lead at Johnson & Johnson Innovative Medicine, shares insights into three significant trends that have potential to reshape the biopharma and biomanufacturing industry
Learn how to enhance your lab's efficiency with Prometheus Panta, from using capillary chips for high-throughput sample loading to solutions for seamless integration in automated workflows
Marius, a biophysics expert at Johnson & Johnson Innovative Medicine, shares his insights into this rapidly evolving field of biomanufacturing.
5 biologics conferences you won’t want to miss in 2025
Use this curated list of must-attend 2025 biologics conferences to plan your year. Find out when and where each conference takes place, who will be there, and what you can expect.
NanoTemper Announces Leadership Evolution: Philipp Baaske Transitions to Executive Chairman
NanoTemper Technologies is entering a new chapter of leadership. After 16 years as Co-CEOs, Philipp Baaske and Stefan Duhr have redefined their roles to better position the company for continued growt
NanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market
NanoTemper Technologies has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper...
NanoTemper Technologies Establishes Advisory Board to Propel Innovation and Growth
NanoTemper Technologies has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper...
5 considerations for buffer optimization during biologics pre-formulation
The work of pre-formulations scientists is critical to de-risk the entire development process for biologics. Read on to learn more about what to consider about your buffer components for...
5 types of formulation excipients and how they impact biologics stability
Each excipient class helps stabilize biologics – from monoclonal antibodies to vaccine antigens – in different ways. Read on to learn more about some of the most important excipients for...
NanoTemper brings Spectral Shift technology to the protein production market with Andromeda X, enabling biopharma and CROs
NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein...
Three things we took away from attending Drug Discovery Chemistry in 2024
Drug Discovery Chemistry is an annual event that focuses solely on early drug discovery, where scientists from around the world gather to showcase their research and participate in thoughtful...
Get predictive insight into your ADC’s stability with these 3 experiments
Learn how it’s possible to use the Prometheus Panta to extrapolate how your low concentration sample will behave once it’s scaled up and at higher concentrations used for clinical administration.
5 biologics conferences you won’t want to miss in 2024
Use this list of crowd-sourced favorites to kick-start your 2024 biologics conference plans. Find out when and where each conference takes place, who will be there, which topics are covered, and...
Attend these targeted protein degradation conferences in 2024 to stay in the know
Attending dedicated targeted protein degradation conferences and tracks is a great way to keep up with this rapidly evolving field. Here are 8 conferences you’ll want to attend in 2024.
De-risk your ADC development process with these stability considerations
Antibody-drug conjugates, or ADCs, are revolutionary therapeutics that represent a growing proportion of the biologics market. They combine the targeting power of a monoclonal antibody, which is...